HRZN · Business Development Company
Horizon Technology Finance Corp
Private credit portfolio and Schedule of Investments data from SEC EDGAR filings.
152
Portfolio Holdings
$646M
Total Fair Value
Filing Information
Top Portfolio Holdings
| Company | Sector | Investment | Coupon | Maturity | Cost | Fair Value |
|---|---|---|---|---|---|---|
| SparkCharge, Inc. (2)(12) | Alternative Energy | Term Loan | 12.00 | $2,398 | $2,398 | |
| Castle Creek Biosciences, Inc. (2)(12) | Biotechnology | Term Loan | 12.00 | March 1, 2028 | $9,947 | $9,947 |
| Emalex Biosciences, Inc. (2)(12) | Biotechnology | Term Loan | 11.47 | May 1, 2026 | $1,665 | $1,665 |
| Greenlight Biosciences, Inc. (2)(12) | Biotechnology | Term Loan | 13.25 | $971 | $971 | |
| KSQ Therapeutics, Inc. (2)(12) | Biotechnology | Term Loan | 10.75 | April 1, 2030 | $4,237 | $4,237 |
| Long Grove Pharmaceuticals, LLC (2)(12) | Biotechnology | Term Loan | 7.87 | February 27, 2031 | $10,086 | $10,086 |
| Native Microbials, Inc (2)(12) | Biotechnology | Term Loan | 12.75 | $2,862 | $2,862 | |
| PDS Biotechnology Corporation (2)(5)(12) | Biotechnology | Term Loan | 13.25 | $8,712 | $8,712 | |
| Provivi, Inc. (2)(12) | Biotechnology | Term Loan | 12.86 | $3,418 | $3,182 | |
| Provivi, Inc. (2)(12)(13) | Biotechnology | Term Loan | 12.11 | January 1, 2027 | $1,683 | $924 |
| Stealth Biotherapeutics Inc. (2)(12) | Biotechnology | Term Loan | 13.00 | $1,999 | $1,999 | |
| Tallac Therapeutics, Inc. (2)(12) | Biotechnology | Term Loan | 12.25 | $2,471 | $2,471 | |
| Axiom Space, Inc. (2)(12) | Communications | Term Loan | 13.75 | $3,731 | $3,731 | |
| Havenly, Inc. (2)(12) | Consumer-related Technologies | Term Loan | 11.75 | $982 | $982 | |
| Havenly, Inc. (2)(12) | Consumer-related Technologies | Term Loan (17) | 10.50 | $1,915 | $3,374 | |
| Lyrical Foods, Inc. (2)(12) | Consumer-related Technologies | Term Loan | 10.25 | $2,771 | $2,400 | |
| Lyrical Foods, Inc. (2)(12) | Consumer-related Technologies | Term Loan (17) | 10.25 | $1,286 | $2,320 | |
| NextCar Holding Company, Inc. (12)(14) | Consumer-related Technologies | Term Loan | 10.00 | 2,266 | $1,079 | — |
| NextCar Holding Company, Inc. (2)(12)(13) | Consumer-related Technologies | Term Loan | 13.50% | $5,415 | $1,271 | |
| Optoro, Inc. (2)(12) | Consumer-related Technologies | Term Loan | 14.00 | $2,448 | $2,448 | |
| Standvast Holdings, LLC (2)(12) | Consumer-related Technologies | Term Loan | 12.75 | $2,339 | $2,267 | |
| Unagi, Inc. (2)(12)(13) | Consumer-related Technologies | Term Loan | 15.25% | $1,086 | — | |
| Hound Labs II, LLC (12) | Diagnostics | Term Loan | 12.75 | 6,789 | $6,605 | — |
| Hound Labs Inc. (12)(13) | Diagnostics | Term Loan | 13.50 | 1,607 | $943 | — |
| Parse Biosciences, Inc. (2)(12) | Diagnostics | Term Loan | 11.50 | 5,000 | $4,659 | — |
About Horizon Technology Finance Corp
Horizon Technology Finance Corp (HRZN) is a publicly traded Business Development Company (BDC) — essentially a publicly listed fund that lends money to mid-sized private companies. In plain English: BDCs raise money from public investors and lend it to businesses that are too small for Wall Street banks. By law, they must pay out at least 90% of their profits as dividends, which is why BDC yields are often 8–12%. Horizon Technology Finance Corp discloses its full loan portfolio through SEC filings.